CALCULATE YOUR SIP RETURNS

Thermax Limited Sells Stake in Covacsis Technologies for ₹10 Crore

Written by: Team Angel OneUpdated on: Apr 4, 2025, 3:31 PM IST
Thermax Limited has divested its stake in Covacsis Technologies through a ₹10 crore deal with Infinite Uptime Inc., USA, an an investment strategy.
Thermax Limited Sells Stake in Covacsis Technologies for ₹10 Crore
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

Thermax Limited has officially announced the sale of its stake in Covacsis Technologies Private Limited. This transaction, completed through a Share Purchase Agreement with Infinite Uptime Inc., USA, results in Covacsis ceasing to be an associate company of Thermax. The sale, executed under SEBI’s Listing Obligations and Disclosure Requirements (LODR) Regulations, signifies a strategic decision by the company.

Details of the Transaction

As per the disclosure made to the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE), the agreement for the sale was signed on 3rd April 2025, with the transaction set for completion on 4th April 2025. The stake was sold for approximately ₹10 crores, and Covacsis had incurred a loss of ₹1.79 crores in FY 2023-24, of which ₹0.30 crores was consolidated into Thermax’s financials. The transaction does not fall under related party transactions, and the buyer is not associated with Thermax’s promoter group.

Regulatory Compliance and Business Impact

Thermax Limited has ensured full compliance with SEBI’s regulatory framework, particularly Regulation 30 of the SEBI (LODR) Regulations, 2015. The sale does not involve a slump sale or a Scheme of Arrangement. By divesting its stake in Covacsis, Thermax aims to realign its investment strategy, focusing on core business areas. This move reflects the company’s intent to streamline operations and optimise financial performance.

Thermax Share Performance 

As of April 04 2025, at 9:50 AM, Thermax share price was trading at ₹3,475.40, reflecting a decline of 2.09% from its previous closing price. Over the past month, it has surged by 8.46%.

Conclusion

The sale of Thermax Limited’s stake in Covacsis Technologies marks a significant corporate development. By executing this transaction, Thermax has restructured its investment portfolio while maintaining compliance with SEBI’s regulations. The move highlights the company’s strategic focus on financial prudence and operational efficiency.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Published on: Apr 4, 2025, 3:31 PM IST

Team Angel One

Team Angel One is a group of experienced financial writers that deliver insightful articles on the stock market, IPO, economy, personal finance, commodities and related categories.

Know More

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Join our 3 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 3 Cr+ happy customers